Relevant bibliographies by topics / Macrocytosis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Macrocytosis'

Author: Grafiati
Published: 24 May 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Macrocytosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Macrocytosis"

1

Pathak, P. K., and L. B. To. "Macrocytosis." Pathology 44 (2012): S36. http://dx.doi.org/10.1016/s0031-3025(16)32685-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Price, J. A., R. Shaarbaf, and L. A. Wood. "Sunitinib-related macrocytosis in patients with advanced renal cell cancer (RCC)." Journal of Clinical Oncology 25, no. 18_suppl (2007): 15580. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15580.

Full text
Abstract:
15580 Background: Sunitinib is an oral multi-targeted tyrosine kinase inhibitor with anti-tumor and anti-angiogenic activity approved and widely used for the treatment of advanced RCC. Based on a clinical observation that several RCC patients receiving Sunitinib developed macrocytosis, this study was performed to describe and examine macrocytosis in this patient population. Methods: A retrospective review of all patients treated with Sunitinib for RCC from 08/05–11/06 was performed. Data regarding hematologic parameters (e.g. CBC, mean corpuscular volume- MCV), concomitant medications, liver f
APA, Harvard, Vancouver, ISO, and other styles
3

Younes, Mohamad, Gilbert Abou Dagher, Jose V. Dulanto, Mario Njeim, and Philip Kuriakose. "Unexplained Macrocytosis." Southern Medical Journal 106, no. 2 (2013): 121–25. http://dx.doi.org/10.1097/smj.0b013e3182824cdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sechi, Leonardo A., Stefano De Carli, and Ettore Bartoli. "Familial macrocytosis." American Journal of Hematology 46, no. 3 (1994): 253. http://dx.doi.org/10.1002/ajh.2830460323.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Yu, Inski, Richard N. Greenberg, Timothy N. Crawford, Alice C. Thornton, and Thein Myint. "Persistence of Macrocytosis after Discontinuation of Zidovudine in HIV-Infected Patients." Journal of the International Association of Providers of AIDS Care (JIAPAC) 16, no. 5 (2017): 512–15. http://dx.doi.org/10.1177/2325957417702486.

Full text
Abstract:
The duration of macrocytosis after stopping zidovudine (ZDV) is unknown. Among 104 HIV-infected patients treated with ZDV for more than 1 year, 84 patients had macrocytosis at ZDV discontinuation. The median mean corpuscular volume (MCV) was 114.6 fL (range 100-128 fL). Patients were divided into 2 groups: those who did (resolved macrocytosis, n = 36) and did not (persistent macrocytosis, n = 48) normalize MCV at 3 to 6 months after ZDV discontinuation. Alcohol use ( P = .02), smoking ( P = .03), and lower (but within normal range) folic acid levels ( P = .05) were related to the persistence o
APA, Harvard, Vancouver, ISO, and other styles
6

Bourlon, Maria Teresa, Dexiang Gao, Sara Trigero, Julia Elizabeth Clemons, Elaine Tat Lam, and Thomas W. Flaig. "Clinical significance of sunitinib-associated macrocytosis in metastatic renal cell carcinoma." Journal of Clinical Oncology 33, no. 7_suppl (2015): 453. http://dx.doi.org/10.1200/jco.2015.33.7_suppl.453.

Full text
Abstract:
453 Background: Increases in mean corpuscular volume (MCV) and hypothyroidism have been observed in patients on sunitinib treatment. We characterized tyrosine kinase-associated macrocytosis in metastatic renal cell carcinoma (mRCC) patients and its relationship, along with thyroid dysfunction, to progression-free survival (PFS). Methods: A retrospective chart review was performed on patients treated with sunitinib and/or sorafenib (01/2005-01/2011). Data pertaining to the development of macrocytosis was analyzed in association with our previous data on thyroid dysfunction in these patients. We
APA, Harvard, Vancouver, ISO, and other styles
7

Sarbay, Hakan. "Evaluation of hematological findings in children with Down syndrome." International Journal of Contemporary Pediatrics 5, no. 5 (2018): 1724. http://dx.doi.org/10.18203/2349-3291.ijcp20183506.

Full text
Abstract:
Background: Various hematological disorders and malignancies may be encountered with Down syndrome. In this article, hematological findings of children with Down syndrome were investigated.Methods: The hematological results of 106 Down syndrome children aged 3 months to 17 years were assessed retrospectively. The results were compared with a patient group consisting of non-DS and healthy children with a similar age range.Results: When compared with the control group, a significant difference was found between the frequencies of neutropenia, monocytosis, macrocytosis and anisocytosis. No signif
APA, Harvard, Vancouver, ISO, and other styles
8

Hands, D. J., B. Eccles, and T. R. Geldart. "An underinvestigated toxicity of sunitinib: Red cell macrocytosis." Journal of Clinical Oncology 29, no. 7_suppl (2011): 371. http://dx.doi.org/10.1200/jco.2011.29.7_suppl.371.

Full text
Abstract:
371 Background: Sunitinib, a multitargeted receptor tyrosine kinase inhibitor represents a standard firstline therapy for advanced renal cell carcinoma. Red blood cell (RBC) macrocytosis (with or without anaemia) is a recognized haematological toxicity but its aetiology remains uncertain. Methods: The medical records of 73 patients (55 male, 18 female) patients treated with sunitinib between 2007 and 2010 at Poole and Bournemouth NHS Trusts, UK were reviewed. Patient demographics, length of treatment, response, RBC mean cell volume (MCV) indices, and known causes of macrocytosis including B12
APA, Harvard, Vancouver, ISO, and other styles
9

Vega, Jose, Mohamad Younes, and Philip Kuriakose. "The Significance of Unexplained Macrocytosis." Blood 112, no. 11 (2008): 3449. http://dx.doi.org/10.1182/blood.v112.11.3449.3449.

Full text
Abstract:
Abstract Background: Macrocytosis is a relatively common finding in adult patients undergoing automated complete blood cell (CBC) counting with an incidence varying from 1.7 % to 3.6 %. Approximately 60% will not have associated anemia. Causes of macrocytosis include alcohol intake, vitamin B12 and folate deficiency, chemotherapy and other drugs, hemolysis or bleeding, liver dysfunction, myelodysplastic syndrome (MDS), and hypothyroidism. Approximately 10% of patients will have unexplained macrocytosis after laboratory evaluation. Data on the diagnostic approach and management of patients with
APA, Harvard, Vancouver, ISO, and other styles
10

Pappo, Alberto S., Barbara W. Fields, and George R. Buchanan. "Etiology of Red Blood Cell Macrocytosis During Childhood: Impact of New Diseases and Therapies." Pediatrics 89, no. 6 (1992): 1063–67. http://dx.doi.org/10.1542/peds.89.6.1063.

Full text
Abstract:
Although an elevated erythrocyte mean corpuscular volume has been noted in many conditions, the relative frequency of various causes of macrocytosis in the pediatric population has not been defined. Therefore, the different medical conditions associated with red cell macrocytosis were retrospectively reviewed. One hundred forty-six children between 6 months and 12 years of age with a mean corpuscular volume ≥ 90 fL were identified during a 13-month period. The most common association with macrocytosis was drug ingestion (anticonvulsants, zidovudine, immunosuppressive agents), observed in 51 (3
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Macrocytosis"

1

Mutenda, Nicholus Mbangu. "Adverse effects experienced by patients on first line antiretroviral drugs used at Keetmanshoop Hospital (Namibia)." University of the Western Cape, 2015. http://hdl.handle.net/11394/4549.

Full text
Abstract:
>Magister Scientiae - MSc<br>Adverse effects are a significant factor that determine how long patients will tolerate a given antiretroviral drug regimen. They also influence treatment options, and play an important role in the much needed adherence to treatment by patients on Highly Active Antiretroviral Therapy (HAART). This study is aimed at understanding adverse effects experienced by patients on the first line antiretroviral therapy at Keetmanshoop Hospital in Namibia. Methods : A retrospective quantitative method was used to review records of patients on first line antiretroviral treat
APA, Harvard, Vancouver, ISO, and other styles
2

Rodrigues, François. "Globules rouges et érythropoïèse au cours du VEXAS." Electronic Thesis or Diss., Université Paris Cité, 2024. https://wo.app.u-paris.fr/cgi-bin/WebObjects/TheseWeb.woa/wa/show?t=8072&f=76103.

Full text
Abstract:
Le VEXAS (Vacuoles, Enzyme E1, X-linked, Auto-Inflammatory, Somatic) est une maladie monogénique somatique en mosaïque restreinte à la lignée hématopoïétique. Décrite en 2020, elle est causée par des mutations du gène UBA1 de la protéine homonyme, principale enzyme E1 de l'ubiquitination chez l'humain. Ces mutations atteignent la méthionine 41, site d'initiation de la traduction de l'isoforme cytoplasmique d'UBA1, et provoquent un déficit d'ubiquitination profond mais restreint au cytoplasme. Les patients atteints de VEXAS souffrent d'une auto-inflammation et présentent des anomalies hématolog
APA, Harvard, Vancouver, ISO, and other styles
3

MEULEBROUCK, TEMPEZ CHRISTINE. "Macrocytose en milieu geriatrique : a propos de 21 cas et revue de la litterature." Amiens, 1991. http://www.theses.fr/1991AMIEM026.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Steele, Benjamin D. "The Masking Effect: A comparison of pre and post folic acid fortification periods for vitamin B-12 deficiency without macrocytosis in the United States." 2014. http://scholarworks.gsu.edu/nutrition_theses/56.

Full text
Abstract:
Background: There has been a concern regarding the masking of vitamin B-12 deficiency in the post-fortification period (after January 1, 1998). Objective: The objective of this study was to investigate the potential masking of vitamin B-12 deficiency by comparing the proportion of individuals with low serum B-12 without macrocytosis between pre- and post-fortification periods using data from the National Health and Nutrition Examination Survey (NHANES). Methods: The study included 7242 individuals from NHANES III (pre-fortification group) and combined NHANES 1999-2000, 2001-2002, 2003-2004, 20
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Macrocytosis"

1

Bunch, Chris. Myelodysplasia. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0288.

Full text
Abstract:
The myelodysplastic syndromes (or myelodysplasias) comprise a spectrum of disorders characterized by dysplastic or ineffective haemopoiesis that leads to variable anaemia, neutropenia, and thrombocytopenia. There is often a degree of red-cell macrocytosis. The majority are clonal stem cell disorders in which the abnormal clone predominates and expands only slowly over a number of years. Myelodysplasias have a tendency to develop ultimately into acute leukaemia in some patients; for this reason, they are sometimes referred to as ‘preleukaemias’, even though two-thirds of patients will never dev
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Macrocytosis"

1

Beck, Norman. "Macrocytosis: The Macrocytic Anemias." In Diagnostic Hematology. Springer London, 2009. http://dx.doi.org/10.1007/978-1-84800-295-1_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

"Macrocytosis." In Clinical Veterinary Advisor. Elsevier, 2012. http://dx.doi.org/10.1016/b978-1-4160-9979-6.00414-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

"macrocytosis, n." In Oxford English Dictionary, 3rd ed. Oxford University Press, 2023. http://dx.doi.org/10.1093/oed/8447624679.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hoffbrand, A. V., and Drew Provan. "Megaloblastic anaemia and miscellaneous deficiency anaemias." In Oxford Textbook of Medicine. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199204854.003.220506_update_002.

Full text
Abstract:
Megaloblastic anaemias are characterized by red blood cell macrocytosis. They arise because of inhibition of DNA synthesis in the bone marrow, usually due to deficiency of one or other of vitamin B<sub>12</sub> (cobalamin) or folate, but sometimes as a consequence of a drug or a congenital or acquired biochemical defect that disturbs their metabolism, or affects DNA synthesis independent of vitamin B...
APA, Harvard, Vancouver, ISO, and other styles
5

Allard, Shubha, and Cecil Reid. "Paediatric haematology." In Practical Paediatric Problems in Primary Care. Oxford University PressOxford, 2007. http://dx.doi.org/10.1093/oso/9780198529224.003.0014.

Full text
Abstract:
Abstract Apart from the platelet count, most other haematological parameters are age related and the appropriate normal range for age will be provided by the laboratory. Physiological changes in the haemoglobin and haematocrit are considered below but it is important to note that after the macrocytosis seen at birth, the mean cell volume (MCV) falls rapidly. Most children are microcytic by adult criteria from 3 months of age with adult values only attained at puberty.
APA, Harvard, Vancouver, ISO, and other styles
6

Prasher, Vee P. "Macrocytosis: a peripheral marker for dementia in Alzheimer’s disease in adults with Down syndrome?" In Down Syndrome and Alzheimer’s Disease. CRC Press, 2018. http://dx.doi.org/10.1201/9781315376875-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hoffbrand, A. V. "Megaloblastic anaemia and miscellaneous deficiency anaemias." In Oxford Textbook of Medicine, edited by Chris Hatton and Deborah Hay. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0536.

Full text
Abstract:
Megaloblastic anaemias are characterized by red blood cell macrocytosis. They arise because of inhibition of DNA synthesis in the bone marrow, usually due to deficiency of one or other of vitamin B<sub>12</sub> (cobalamin) or folate, but sometimes as a consequence of a drug or a congenital or acquired biochemical defect that disturbs vitamin B<sub>12</sub> or folate metabolism, or affects DNA synthesis independent of vitamin B<sub>12</sub> or folate. Acquired pernicious anaemia—antibodies in serum and gastric juice directed against parietal cells (85–90% of cases) and intrinsic factor (50%), a
APA, Harvard, Vancouver, ISO, and other styles
8

Kumar, Neeraj. "Progressive Imbalance and Visual Impairment in a Patient With Diabetes." In Mayo Clinic Cases in Neuroimmunology, edited by Andrew McKeon, B. Mark Keegan, and W. Oliver Tobin. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780197583425.003.0081.

Full text
Abstract:
A 72-year-old man with hypothyroidism and type 2 diabetes sought care for a 3-year history of slowly progressive, ascending lower limb paresthesias and imbalance. Three months earlier, he noted subacute onset of finger numbness and substantial worsening of imbalance with infrequent falls. He also had a 1-year history of progressive visual decline that persisted despite cataract surgery. Additional symptoms included intermittent light-headedness and confusion. Laboratory evaluations showed a decreased hemoglobin value and an increased mean corpuscular volume. Macrocytic red blood cells were not
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Macrocytosis"

1

Takenaka, M., T. Furui, Y. Bomoto, S. Murase, Y. Hayasaki, and K.-I. Morishige. "EP993 Macrocytosis associated with olaparib." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.1037.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mukerji, B. "FRI0001 Folinic acid supplementation reverses macrocytosis without altering efficacy in patients with arthritis treated with methotrexate." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.1130.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Macrocytosis' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography